In 1988, The Bethesda System (TBS) introduced the phrase atypical
|
|
- Dorcas Turner
- 5 years ago
- Views:
Transcription
1 CANCER CYTOPATHOLOGY 93 Should the Cytologic Diagnosis of Atypical Squamous Cells of Undetermined Significance Be Qualified? An Assessment Including Comparison between Conventional and Liquid-Based Technologies Rose C. Anton, M.D. Ibrahim Ramzy, M.D. Mary R. Schwartz, M.D. Pamela Younes Subhendu Chakraborty Dina R. Mody, M.D. Department of Pathology, Baylor College of Medicine, Houston, Texas. BACKGROUND. The diagnosis of atypical squamous cells of undetermined significance (ASCUS) remains an enigma for the treating physician, because it encompasses both benign, reactive, as well as preneoplastic and possibly neoplastic conditions. To address this problem, The Bethesda System recommends qualifying the ASCUS diagnosis. This study analyzes the difference in the follow-up results between the various groups of patients with an ASCUS diagnosis as outlined by the Criteria Committee: favor premalignant (ASCUS-P), favor reactive (ASCUS-R), and unqualified (ASCUS-C). The outcome, based on follow-up biopsies and/or cytologies, for both the conventional Papanicolaou smear (CS) and liquid-based (LB) methodologies is compared. METHODS. The CS and LB biopsies and/or cytologies included 590 patients and 137 patients, respectively, who had an initial diagnosis of ASCUS. The final outcome after subsequent biopsy and cytology within a 1-year period for each methodology was tabulated. Furthermore, the addition of qualifiers for each diagnosis was tabulated for both cytology and biopsy follow-up and compared between CS and LB technologies. RESULTS. For CS, 29 patients (8.6%) were found to have squamous intraepithelial lesions (SIL) on subsequent cytologic smears, and 176 patients (63.7%) had SIL on biopsy follow-up. For LB, these numbers were 17 patients (19.1%) and 56 patients (65.1%), respectively. Regardless of the qualification used in the initial CS biopsy or cytology, over 90% of the subsequent smears resulted in a benign diagnosis. Biopsy outcomes after CS diagnoses of ASCUS-P, ASCUS-R, and ASCUS-C showed SIL in 80%, 53%, and 66% of patients, respectively. For LB diagnoses, subsequent smears detected SIL in 33% of patients with a diagnosis of ASCUS-P, 22% of patients with a diagnosis of ASCUS-R, and 12% of patients with a diagnosis of ASCUS-C. Biopsy outcomes after LB diagnoses of ASCUS-P, ASCUS-R, and ASCUS-C showed SIL in 68%, 64%, and 66% of patients, respectively. CONCLUSIONS. There appears to be no statistically valid benefit from a clinical point of view in qualifying an ASCUS interpretation by either CS or LB, except for CS evaluation of patients with a diagnosis of ASCUS-P. Cancer (Cancer Cytopathol) 2001;93: American Cancer Society. Address for reprints: Rose C. Anton, M.D., The Methodist Hospital, MS-205, 6565 Fannin St., Houston, Texas ; Fax: ; ranton@bcm.tmc.edu. Received May 1, 2000; revision received November 30, 2000; accepted December 6, KEYWORDS: cervical cytology, smears, cervix, carcinoma, Papanicolaou, screening, dysplasia. In 1988, The Bethesda System (TBS) introduced the phrase atypical squamous cells of undetermined significance (ASCUS) as the preferred terminology for the arbitrary and often overused term atypia American Cancer Society
2 94 CANCER (CANCER CYTOPATHOLOGY) April 25, 2001 / Volume 93 / Number 2 In this new classification, ASCUS is defined as squamous cell abnormalities that are not directly attributable to reactive cellular changes but that fall short of the criteria diagnostic for squamous intraepithelial lesion (SIL). Because the term ASCUS does not represent a specific diagnostic pathologic entity but, rather, a spectrum of cellular changes ranging from benign to preinvasive lesions, this entity often creates a dilemma for the treating physician. The clinical and biologic significance of ASCUS on cytologic smears remains unknown due in large part to the broad range ( %) in reported prevalence rates of SIL in women whose Papanicolaou (Pap) smears were reported as ASCUS The majority of these diagnoses, however, represent low grade lesions, with very few women having invasive disease, and only 15 30% of all SIL representing high grade lesions. 4,11 14 Although a Pap smear interpretation of high grade SIL or a macroscopically obvious cervical lesion are accepted indications for colposcopy and biopsy, the ideal management of patients with lesser lesions remains controversial. Despite the relatively low but clinically significant risk for a woman to be diagnosed with a high grade SIL after an initial diagnosis of ASCUS on Pap smear, many advocate immediate referral to colposcopy to avoid the possibility of failing to diagnose a high grade lesion. Other experts say that the safest and most cost-effective management of these patients is the performance of serial Pap smears with the addition of colposcopy only if a significant lesion becomes evident on the subsequent smears. To assist the treating physician in selecting the most appropriate treatment plan, TBS recommends that the cytologist further qualify the ASCUS diagnosis on the basis of whether a reactive process or a preneoplastic process is favored. Although proper communication with the treating physician is ideal in conveying a level of concern regarding an ASCUS smear, it is not always feasible. This is especially true with the advent of managed care, in which smears may be interpreted in laboratories at some distance from the patient. In addition, the diagnosis of ASCUS is inherently subjective and susceptible to intraobserver and interlaboratory variation. 4,12,14 It appears that, in today s medical practice, ascertaining the true optimal, cost-effective patient management after an ASCUS interpretation is innately unattainable. In recent years, liquid-based (LB), thin-layer technologies have shown promise in reducing the false negative rate of the conventional Pap smear (CS). A similar reduction in the ASCUS rate has been suggested. These LB preparations may help decrease the often wastebasket use of ASCUS by improved sensitivity: increasing cell number and, thus, curtailing the possibility of sampling error; reducing obscuring material (such as blood, mucus, and inflammation); and limiting preparation artifacts. To the best of our knowledge, no published report has examined the results and follow-up data after an initial ASCUS diagnosis by both LB and CS technologies and the diagnostic significance of the addition of qualifiers to subcategorize the ASCUS diagnosis. Therefore, this study was designed to evaluate the differences in patient outcome on follow-up cytology or biopsy of the three categories of ASCUS, as outlined by the Bethesda System Criteria Committee: reactive (ASCUS-R), premalignant (ASCUS-P), and unqualified (ASCUS-C). In addition, ASCUS follow-up for LB and CS are compared to determine whether the use of qualifiers is more applicable for either of the methodologies. MATERIALS AND METHODS Eight hundred sixty-five patients had a diagnosis of ASCUS with follow-up biopsies or cytologies within a 1-year period at one of the laboratories in our institution (Baylor College of Medicine, Houston, TX), which provides cytology and histology services to a single, large group of gynecologists in private practice. These included 704 patients with CS and 161 patients with LB preparations. Patients who had follow-up cytologies consisting only of ASCUS or AGUS were excluded, leaving 590 patients and 137 patients respectively for the study. The cytologic criteria used to determine ASCUS were those outlined by TBS. At the time of the original sign-out, the cytopathologist indicated whether an ASCUS-R, ASCUS-C, or ASCUS-P process was favored. The cytologic and histologic outcomes obtained after the initial ASCUS diagnosis were tabulated under the following categories: within normal limits (WNL), benign cellular changes (BCC), low grade SIL (LSIL), or high grade SIL (HSIL). The numbers of patients with benign (WNL or BCC) or SIL (LSIL or HSIL) diagnoses on cytologic and histologic follow-up for each ASCUS qualification were recorded for both groups. Statistical Analysis A Fisher exact chi-square test was performed to determine the significance of cytology and/or biopsy outcome data after an initial ASCUS diagnosis by either CS or LB technologies (Stata Inc., College Station, TX). The use of qualifiers was then assessed to determine whether subcategorizing an ASCUS diagnosis by either CS or LB technologies proved significant. P values 0.05 were considered statistically significant.
3 Should ASCUS Be Qualified?/Anton et al. 95 FIGURE 1. The results of cytologic evaluations after an initial diagnosis of atypical squamous cells of undetermined significance from conventional smears and liquid-based preparations. WNL: within normal limits; BCC: benign cellular changes; LSIL: low grade squamous intraepithelial lesion; HSIL: high grade squamous intraepithelial lesion. FIGURE 2. The results of biopsies after an initial diagnosis of atypical squamous cells of undetermined significance from conventional smears and liquid-based preparations. WNL: within normal limits; BCC: benign cellular changes; LSIL: low grade squamous intraepithelial lesion; HSIL: high grade squamous intraepithelial lesion. Finally, positive and negative predictive values for an ASCUS qualification by CS or LB were generated. RESULTS CS Three hundred thirty-six patients had follow-up cytologic smears obtained within 1 12 months after the initial ASCUS diagnosis, with a mean of 8.3 months. After the initial diagnosis of ASCUS, the results in 52 patients (15.5%) were WNL, the results in 255 patients (75.9%) showed BCC, the results in 25 patients (7.4%) showed LSIL, and the results in 4 patients (1.2%) showed HSIL. Hence, 307 patients (91.4%) had follow-up cytologic results that were benign, and 29 patients (8.6%) has results that showed SIL. These results are demonstrated in Figure 1. The overall results for 276 patients who had follow-up biopsies within a 1-year period are summarized in Figure 2. The follow-up biopsies were obtained within 1 12 months after the initial ASCUS diagnosis, with a mean of 2.6 months. After the initial interpretation of ASCUS, the follow-up biopsies for 100 patients (36.3%) were nonneoplastic. Eleven patients (4.0%) had biopsies that demonstrated no pathologic alteration, and 89 patients (32.3%) had biopsies that showed BCC. One hundred seventy-six patients (63.7%) demonstrated SIL on a follow-up biopsy, of which 166 (60.1%) were LSIL, and 10 (3.6%) were HSIL. Seventy-five patients had a qualified ASCUS-P diagnosis on a conventional smear. Seventy of these patients (93%) had a benign diagnosis on a follow-up cytologic smear, with only 5 patients (7%) demonstrating SIL. Of the 172 patients with an initial qualified ASCUS-R diagnosis, 162 patients (94%) demonstrated WNL or BCC on a follow-up smear, and 10 patients FIGURE 3. The results from patients who had benign cytologic evaluations after the initial qualification of a diagnosis of atypical squamous cells of undetermined significance (ASCUS) from conventional smears and liquid-based preparations. ASCUS-R: reactive ASCUS; ASCUS-P: premalignant ASCUS; ASCUS-C: unqualified ASCUS. (6%) had SIL. Among the 93 ASCUS patients who could not be subcategorized further, 87 patients (94%) eventually showed WNL or BCC, and 6 patients (6%) demonstrated SIL. These results are summarized in Figures 3 and 4. Figures 5 and 6 summarize the outcome data for 250 patients who had a biopsy after their initial ASCUS diagnosis with qualification. For the 99 patients who were subcategorized with ASCUS-P, most (79 patients, 80%) were found to have SIL on the subsequent biopsy. The 89 patients who were favored to have a reactive process (ASCUS-R) showed results that were more divergent: 42 patients (47%) demonstrated a benign diagnosis on follow-up, whereas 47 patients (53%) showed SIL. Most of the 62 patients whose smears could not be subcategorized further showed SIL on follow-up (41 patients; 66%). LB Eighty-nine patients had follow-up cytologic smears obtained within 1 12 months after the initial ASCUS
4 96 CANCER (CANCER CYTOPATHOLOGY) April 25, 2001 / Volume 93 / Number 2 FIGURE 4. The results from patients who had squamous intraepithelial lesions on cytologic evaluation after the initial qualification of a diagnosis of atypical squamous cells of undetermined significance (ASCUS) with conventional smears and liquid-based preparations. ASCUS-R: reactive ASCUS; ASCUS-P: premalignant ASCUS; ASCUS-C: unqualified ASCUS. FIGURE 6. The results from patients who had squamous intraepithelial lesions on biopsy evaluation after the initial qualification of a diagnosis of atypical squamous cells of undetermined significance (ASCUS) with conventional smears and liquid-based preparations. ASCUS-R: reactive ASCUS; ASCUS-P: premalignant ASCUS; ASCUS-C: unqualified ASCUS. FIGURE 5. The results from patients with benign biopsies after the initial qualification of a diagnosis of atypical squamous cells of undetermined significance (ASCUS) with conventional smears and liquid-based preparations. ASCUS-R: reactive ASCUS; ASCUS-P: premalignant ASCUS; ASCUS-C: unqualified ASCUS. diagnosis, with a mean of 8.1 months. After the initial diagnosis of ASCUS, 72 patients (80.9%) had follow-up cytologies that were benign. Three patients (3.4%) had smears that showed WNL, and 69 (77.5%) demonstrated BCC. Seventeen patients (19.1%) showed SIL, of which 14 patients (15.7%) displayed LSIL, and 3 (3.4%) had HSIL. These results are summarized in Figure 1. The overall results for 86 patients who had follow-up biopsies within a 1-year period are summarized in Figure 2. The follow-up biopsies were obtained within 1 12 months after the initial ASCUS diagnosis, with a mean of 2.5 months. After the initial interpretation of ASCUS, the follow-up biopsies for 30 patients (34.9%) were benign. Twelve patients (14.0%) had biopsies that demonstrated no pathologic alteration, and 18 patients (20.9%) had biopsies that showed BCC. Fifty-six patients (65.1%) demonstrated SIL on a follow-up biopsy, of which 49 patients (57.0%) had LSIL, and 7 patients (8.1%) had HSIL. Eighteen patients had a qualified ASCUS-P diagnosis on a conventional smear. Twelve of these patients (67%) had a benign diagnosis on a follow-up cytologic smear. The remaining six patients (33%) demonstrated SIL on a subsequent smear. Of the 32 patients with an initial qualified ASCUS-R diagnosis, 25 (78%) demonstrated WNL or BCC on a follow-up smear. Seven patients (22%) had SIL on follow-up. Among the 40 patients with ASCUS who could not be subcategorized further, 35 patients (88%) eventually showed WNL or BCC, and 5 patients (12%) demonstrated SIL. These results are summarized in Figures 3 and 4. Figures 5 and 6 summarize the outcome data for 88 patients who had a colposcopy/biopsy after their initial ASCUS diagnosis with qualification. For the 31 patients who were subcategorized with ASCUS-P, most (21 patients; 68%) were found to have SIL on the subsequent biopsy, and the remaining 10 patients (32%) had a negative diagnosis. Sixteen of 25 patients (64%) who initially were believed to have a reactive process demonstrated SIL on histologic examination, whereas only 9 patients (36%) eventually were found to have a benign diagnosis. Most of the 32 patients who could not be subcategorized further showed SIL on follow-up (21 patients; 66%). Eleven patients (34%) demonstrated a benign process. Statistical Analysis An ASCUS diagnosis by LB technology was far more likely to result in an SIL diagnosis on cytology followup, with 17 of 89 patients who had an SIL outcome compared with 29 of 336 patients by CS (P ). The results remained statistically significant when cytology and biopsy follow-up data were combined, with
5 Should ASCUS Be Qualified?/Anton et al. 97 an SIL outcome in 73 of 175 patients by LB compared with 205 of 612 patients by CS (P ). However, when only the biopsy data were analyzed, the results were insignificant (56 of 86 patients by LB vs. 176 of 276 patients by CS; P ). The cytology, biopsy, and combined cytology and biopsy follow-up data subsequent to an initial ASCUS diagnosis with qualification on CS were then analyzed. The results for cytology follow-up were not significantly different for any ASCUS qualification: ASCUS-P versus ASCUS-R (P ), ASCUS-P versus ASCUS-C (P ), or ASCUS-R versus ASCUS-C (P ). The biopsy results proved highly significant for an ASCUS-P diagnosis compared with an ASCUS-R diagnosis (P ). However, it remained insignificant for an ASCUS-P diagnosis compared with an ASCUS-C diagnosis (P ) and an ASCUS-R compared with an ASCUS-C diagnosis (P ). When the cytology and biopsy follow-up results were combined, an ASCUS-P diagnosis compared with an ASCUS-R diagnosis was significant (P ), and an ASCUS-P diagnosis compared with an ASCUS-C diagnosis was significant (P ), whereas the ASCUS-R qualification compared with the ASCUS-C qualification approached significance (P ). The data for an ASCUS qualification by LB methodology indicate that these qualifications are even less helpful in suggesting SIL or a reactive lesion compared with the CS methodology. The cytology outcome values were insignificant for ASCUS-P compared with ASCUS-R (P ), ASCUS-P compared with ASCUS-C (P ), and ASCUS-R compared with ASCUS-C (P ). Likewise, the biopsy data were insignificant for all comparisons: ASCUS-P versus ASCUS-R (P ), ASCUS-P versus ASCUS-C (P ), and ASCUS-R versus ASCUS-C (P ). For the cytology and biopsy combined follow-up, ASCUS-P versus ASCUS-C was the only significant comparison (P ), whereas ASCUS-P versus ASCUS-R and ASCUS-R versus ASCUS-C remained insignificant (P and P , respectively). The positive predictive value of an ASCUS-P interpretation by CS was 6.7% for cytology follow-up, 79.8% for biopsy follow-up, and 48.3% for cytology and biopsy follow-up data combined. The corresponding positive predictive values by LB were 33.3%, 67.7%, and 55.1%, respectively. The negative predictive value of an ASCUS-R interpretation by CS was 94.2% for cytology follow-up, 53.9% for biopsy followup, and 78.2% for cytology and biopsy follow-up data combined. The corresponding negative predictive values by LB were 78.1%, 36.0%, and 59.6%, respectively. DISCUSSION Since its introduction over 50 years ago, the Pap smear has become a valuable screening tool for the detection of cervical carcinoma. More recently, newer methodologies, including LB smears and human papilloma virus testing, have been added in an attempt to increase the sensitivity of the procedure. Several studies have reported an increase in SIL detection with LB smears Comparisons of the ASCUS category between CS and LB have been less clear cut. Previously published studies have reported both increased and decreased ASCUS rates, further confusing the ASCUS 16,19 22 interpretation. Since the incorporation of LB preparations at our institution, the percentage of patients diagnosed with ASCUS decreased from an initial rate of 6.8% to 3.2%, with 70% of our volume consisting of LB preparations during the study period. Our study summarizes the outcome data (biopsy and cytology) after an initial ASCUS interpretation on CS and LB of a large private practice, low risk population. The data regarding subsequent cytologic smears demonstrate an enhanced SIL detection rate with the LB methodology (19% by LB compared with 9% by CS; P ). The reported improved quality and quantity of cells offered by this technique may play some role. However, this study is limited by the fact that the subsequent cytologic smears after the initial LB ASCUS interpretation consisted of both CS and LB smears. Therefore, no definite conclusion can be drawn between the two methodologies based on the cytology results alone. Similar to previous reports, our colposcopy with biopsy follow-up data were far more sensitive in the detection of SIL than subsequent smears for both CS (63.7% vs. 8.6%) and LB (65.1% vs. 19.1%). This is most likely because of the better visualization and direct sampling offered by colposcopy. However, patient selection bias by the treating physician cannot be excluded entirely. Significantly, however, our data recognize that ASCUS interpretations by LB and CS technologies yielded similar SIL detection rates on subsequent biopsies (65.1% vs. 63.7%, respectively; P ). These findings echo those of Carpenter and Davey 19 and indicate that an ASCUS interpretation by LB warrants management protocols similar to those for CS. Fortunately, the great majority of SIL on subsequent biopsy are low grade, with LB preparations having a slight edge in detecting HSIL (13% of SIL vs. 6% of HSIL, respectively). Overall, the above data parallel what has been reported previously in the literature, in which SIL has been demonstrated in 58 72% of women who had follow-up biopsies. 8,14,23 However, several other stud-
6 98 CANCER (CANCER CYTOPATHOLOGY) April 25, 2001 / Volume 93 / Number 2 ies reported a slightly lower SIL rate. Selvaggi and Haefner 11 noted SIL in 37% of subsequent tissue specimens. Forty-six percent of women in the study by Auger et al. 24 had SIL or invasive carcinoma on subsequent biopsy. Carpenter and Davey, 19 in a study comparing LB and CS smears, noted an SIL outcome in 21% and 24% of patients, respectively. Our data concerning ASCUS qualifications are unique. Regardless of the qualification used in the initial CS, over 90% of the subsequent smears resulted in a benign diagnosis. Ninety-three percent of women who were favored to harbor a preneoplastic lesion ultimately were diagnosed with a normal or reactive pattern. Similar results were noted for women whose initial ASCUS interpretation by LB resulted in a subsequent smear: two-thirds in the favor neoplastic category had a negative diagnosis on subsequent smear. Because the repeat smears obtained after the initial ASCUS diagnosis by LB consisted of both CS and LB smears, we cannot consider the cytology follow-up as our gold standard for this study. More relevant are the data obtained after subsequent biopsy, because issues concerning the final outcome procedure and sampling are similar. Eighty percent of women in the ASCUS favor preneoplastic category after CS were diagnosed with SIL on follow-up biopsy. Favor reactive was more equivocal, with an almost equal likelihood of indicating SIL (53%) or a negative finding (47%). The biopsy outcome for LB smears reflects the cytology data, with an equal probability of SIL regardless of the qualification. When comparing ASCUS qualifications for CS and LB technologies, the only value that proved statistically significant using the biopsy outcome data was the increased likelihood of finding SIL with an ASCUS-P interpretation compared with an ASCUS-R interpretation by CS (P ). In general, our results indicate little practical benefit from qualifying an ASCUS diagnosis. The uniformity of the data obtained by the LB technique may reflect a comfort level as cytologists adjust to a new technique. As cytotechnologists and pathologists gain more experience in LB interpretation, the outcome results for ASCUS qualifications may become more divergent. Our findings are not in accord with the majority of previous studies, the findings of which champion the value of qualification. Ettler et al. 25 found SIL in 73% of their favor dysplasia group and a negative diagnosis in 73% of the favor reactive group. The figures cited by Gonzalez et al. 26 demonstrate a very low SIL rate, regardless of further classification. Six percent of the favor reactive smears and 30% of the favor dysplasia smears resulted in SIL in the study by Genest et al. 27 Ten percent of women in the favor reactive group of Collins et al. 28 resulted in an SIL diagnosis. Kline and Davey 29 noted that only the favor dysplastic category was useful in their laboratories, with an SIL outcome rate of 30% for their favor reactive category. These findings were corroborated by Malik et al., 30 who, although they found that 78% of women in the favor dysplasia category had SIL, noted SIL in 48% of women in the favor reactive category. 30 It appears that the clinical utility of qualification varies among laboratories. When comparing the positive predictive values of an ASCUS-P interpretation by CS and LB technologies, we found that CS was associated more strongly with SIL on biopsy follow-up than LB (79.8% vs. 67.7%, respectively) due to the lower false positive rate seen with CS. Similarly, CS proved superior to LB when assessing the false negative rate of an ASCUS-R interpretation (53.9% vs. 36.0%, respectively). In other words, an ASCUS-P diagnosis qualified by CS was more likely to result in the detection of SIL on follow-up compared with an ASCUS-P diagnosis qualified by LB, and an ASCUS-R diagnosis qualified by CS was more likely to be benign on follow-up than an ASCUS-R diagnosis qualified by LB. One reason for our unique findings may be the interobserver variation and the lack of reproducibility of the criteria used to establish the favor reactive or preneoplastic categories, comparable to the hypothesis attempting to explain the wide variation in SIL rates after the initial ASCUS diagnosis. The use of cytologic and/or histologic correlations is a valid laboratory quality-assurance tool that may help standardize these rates. In summary, the current study demonstrates that a number of patients who are diagnosed with ASCUS in all categories by either CS or LB methodologies have ASCUS associated with a clinically significant number of SILs, warranting further patient evaluation. Although no definite conclusion concerning optimal patient management can be drawn, we feel that the benefit of adding qualifiers to the ASCUS interpretation will vary among laboratories but can play some role in assisting the treating physician. The ideal approach may be laboratory independent and may rest with individualizing each patient based on their history, clinical suspicion, and patient compliance. REFERENCES 1. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262: Abu-Jawdeh GM, Trawinski G, Nang HH. Histocytological study of squamous atypia on pap smears. Mod Pathol 1994; 7:920 4.
7 Should ASCUS Be Qualified?/Anton et al Busseniers AE, Sidawy MD. Inflammatory atypia on cervical smears: a diagnostic dilemma for the gynecologist. J Reprod Med 1991;36: Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol 1994;11: Davis GL, Hernandez E, Davis JL, Miyazawa K. Atypical squamous cells in Papanicolaou smears. Obstet Gynecol 1987;69: Jones DE, Creasman WT, Dombroski RA, Lentz SS, Waeltz JL. Evaluation of the atypical Pap smear. Am J Obstet Gynecol 1987;157: Noumoff JS. Atypia in cervical cytology as a risk factor for intraepithelial neoplasia. Am J Obstet Gynecol 1987;156: Sidawy MK, Tabbara SO. Reactive change and atypical squamous cells of undetermined significance in Papanicolaou smears: a cytohistologic correlation. Diagn Cytopathol 1993; 9: Slawson DC, Bennett JH, Herman JM. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? Family Pract 1993;36: Soutter WP, Wisdom S, Brough AK, Minaghan JM. Should patients with mild atypia in a cervical smear be referred for colposcopy? Br J Obstet Gynaecol 1986;93: Selvaggi SM, Haefner HK. Reporting of atypical squamous cells of undetermined significance on cervical smears: is it significant? Diagn Cytopathol 1995;13: Solomon D, Frable WJ, Vooijs GP, Wilbur DC, Amma NS, Davey DD, et al. ASCUS and AGUS criteria: IAC Task Force summary. Acta Cytol 1998;42: Wilbur DC, Bonfiglio TA. Atypical squamous cells in cervical smears: resolving a controversy [editorial]. Diagn Cytopathol 1993;9: Williams ML, Rimm DL, Pedigo MA, Frable WJ. Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol 1997;16: Austin RM, Ramzy I. Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data. Acta Cytol 1998;42: Dupree WB, Suprun HZ, Beckwith DG, Shane JJ, Lucente V. The promise and risk of new technology. The Lehigh Valley Hospital s experience with liquid-based cervical cytology. Cancer 1998;84: Linder J, Zahniser D. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology. Arch Pathol Lab Med 1998;122: Roberts JM, Gurley AM, Thurloe JK, Bowditch R, Laverty CR. Evaluation of the ThinPrep Pap test as an adjunct to the conventional Pap smear. Med J Aust 1997;167: Carpenter AB, Davey DD. ThinPrep Pap test: performance and biopsy follow-up in a university hospital. Cancer 1999; 87: Bolick DR, Hellamn DJ. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol 1998;42: Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL. Comparison of conventional Papanicolaou smears and fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997;90: Papillo JL, Zarka MA, St. John PL. Evaluation of the ThinPrep Pap test in clinical practice: a seven month, 16,314-case experience in northern Vermont. Acta Cytol 1998;42: Dvorak KA, Finnemore M, Maksem JA. Histology correlation with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) cytology diagnoses: an argument to ensure ASCUS follow-up that is as aggressive as that for LSIL. Diagn Cytopathol 1999;21: Auger M, Charbonneau M, Arseneau J. Atypical squamous cells of undetermined significance: a cytohistologic study of 52 cases. Acta Cytol 1997;41: Ettler HC, Joseph MG, Downing PA, Suskin NG, Wright VC. Atypical squamous cells of undetermined significance: a cytohistological study in a colposcopy clinic. Diagn Cytopathol 1999;21: Gonzalez D, Hernandez E, Anderson L, Heller P, Atkinson BF. Clinical significance of cervical cytologic diagnosis of atypical squamous cells of undetermined significance: favoring a reactive process or low grade squamous intraepithelial lesion. J Reprod Med 1996;41: Genest DR, Dean B, Lee KR, Sheets E, Crum C, Cibas ES. Qualifying the cytologic diagnosis of atypical squamous cells of undetermined significance affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy. Arch Pathol Lab Med 1998;122: Collins LC, Wang HH, Abu-Jawdeh MA. Qualifiers of atypical squamous cells of undetermined significance help in patient management. Mod Pathol 1996;9: Kline MJ, Davey DD. Atypical squamous cells of undetermined significance qualified: a follow-up study. Diagn Cytopathol 1996;14: Malik SH, Wilkinson EJ, Drew PA, Bennett BB, Hardt NS. Do qualifiers of ASCUS distinguish between low- and high-risk patients? Acta Cytol 1999;43:
The Korean Journal of Cytopathology 13(1): 14-20, 2002
13 1 The Korean Journal of Cytopathology 13(1): 14-20, 2002 : ASCUS 1941 Papanicolaou. The Bethesda System(TBS) 1) 1988, atypical squamous cells of undetermined significance(ascus), low-grade squamous
More informationCervical cytology screening has led to a reduction in cancer mortality
CANCER CYTOPATHOLOGY 105 ThinPrep Pap Test Performance and Biopsy Follow-Up in a University Hospital A. Betts Carpenter, M.D., Ph.D. Diane D. Davey, M.D. Department of Pathology and Laboratory Medicine,
More informationIn 1988, the National Cancer Institute developed the Bethesda System. Atypical Squamous Cells of Undetermined Significance on Cervical Smears CANCER
74 CANCER CYTOPATHOLOGY Atypical Squamous Cells of Undetermined Significance on Cervical Smears Follow-Up Study of an Asian Screening Population Annie N. Y. Cheung, M.D. Elaine F. Szeto, B.Sc. Kin-Man
More informationComparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears
The Korean Journal of Pathology 2012; 46: 365-369 ORIGINAL ARTICLE Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears Jung Dal Lee 1,2
More informationCAP Laboratory Improvement Programs
CAP Laboratory Improvement Programs Comparison of Performance of Conventional and ThinPrep Gynecologic Preparations in the College of American Pathologists Gynecologic Cytology Program Andrew A. Renshaw,
More informationThe diagnostic category of atypical squamous cells of undetermined
100 CANCER CYTOPATHOLOGY Significance of a Diagnosis of Atypical Squamous Cells of Undetermined Significance for Papanicolaou Smears in Perimenopausal and Postmenopausal Women Jeffrey T. Keating, M.D.
More informationLong-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance
Anatomic Pathology / LONG-TERM OUTCOME WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance Stephen
More informationINTRODUCTION HSIL AND CERVICAL CARCINOMA IN ASCUS CERVICAL CYTOLOGY
HSIL AND CERVICAL CARCINOMA IN ASCUS CERVICAL CYTOLOGY PREVALENCE OF HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) AND INVASIVE CERVICAL CANCER IN PATIENTS WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED
More informationCervical Precancer: Evaluation and Management
TAJ June 2002; Volume 15 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Review fam Cervical Precancer: Evaluation and Management SM Khodeza Nahar Begum 1 Abstract Carcinoma of
More informationPAP SMEAR WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE
Arch Iranian Med 2005; 8 (3): 192 196 Original Article PAP SMEAR WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE Fatemeh Ghaemmaghami MD *, Fereshteh Ensani MD**, Nadereh Behtash MD* Ebrahim
More informationOutcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure
The Korean Journal of Pathology 2012; 46: 359-364 ORIGINAL ARTICLE Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure Joon Seon Song Ilseon
More informationThe AutoPap Primary Screening System (APSS; Tripath Imaging,
CANCER CYTOPATHOLOGY 129 A Feasibility Study of the Use of the AutoPap Screening System as a Primary Screening and Location-Guided Rescreening Device Massimo Confortini, M.D. 1 Lucia Bonardi, M.D. 1 Paolo
More informationAtypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing
Anatomic Pathology / ATYPICAL GLANDULAR CELLS AND HUMAN PAPILLOMAVIRUS Atypical Glandular Cells of Undetermined Significance Outcome Predictions Based on Human Papillomavirus Testing Jeffrey F. Krane,
More informationAtypical Epithelial Cells and Specimen Adequacy
Atypical Epithelial Cells and Specimen Adequacy Current Laboratory Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology Diane
More informationAwatif Al-Nafussi, Gemma Rebello, Raja Al-Yusif, Euphemia McGoogan
J Clin Pathol 2000;53:439 444 439 Papers Department of Pathology, Medical School, Teviot Place, Edinburgh EH8 9AG, UK A Al-Nafussi G Rebello R Al-Yusif E McGoogan Correspondence to: Dr Al-Nafussi email:
More informationEvaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear
The Korean Journal of Pathology 2010; 44: 528-35 DOI: 10.4132/KoreanJPathol.2010.44.5.528 Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions
More informationThe comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting
BJOG: an International Journal of Obstetrics and Gynaecology November 2005, Vol. 112, pp. 1542 1546 DOI: 10.1111/j.1471-0528.2005.00699.x The comparative diagnostic accuracy of conventional and liquid-based
More information488 Diagnostic Cytopathology, Vol 35, No 8 ' 2007 WILEY-LISS, INC.
Direct-to-Vial Comparison of a New Liquid-Based Cytology System, Liqui-PREP TM Versus the Conventional Pap Smear Joonseok Park, M.D., 1 * Eun-Ha Jung, M.D., 2 Changok Kim, M.D., 2 and Young Hee Choi, M.D.
More informationHPV Testing & Cervical Cancer Screening:
HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success
More informationGYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital
GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital and Bioreference Labs (Houston) Department of Pathology
More informationSara J. Bernstein, MD, Luis Sanchez-Ramos, MD, and Boniface Ndubisi, MD Jacksonville, Fla
Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: A metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy Sara J. Bernstein, MD, Luis Sanchez-Ramos,
More informationANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION
Electronic Journal of Pharmacology and Therapy Vol 4, 15-20 (2011) ISSN: 0973-9890 (Available online at wwwtcrjournalscom) Clinical Article ndexed in: ProQuest database Abstract, USA (ProQuest Science
More informationCAP Laboratory Improvement Programs
CAP Laboratory Improvement Programs Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006 Galen M. Eversole, MD; Ann T. Moriarty,
More informationAgreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology
Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology Andrew M. Quinn, MD 1 ; Abu T. Minhajuddin, PhD 2 ; Linda S. Hynan, PhD
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More informationCervical Cancer Prevention by Liquid-Based Cytology in a Low-Resource Setting
Cervical Cancer Prevention by Liquid-Based Cytology in a Low-Resource Setting 7 Mongkol Benjapibal and Somsak Laiwejpithaya Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital,
More informationWELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1
WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1 HOW TO CITE THIS ARTICLE: G. J. Vani Padmaja. Well Woman Clinic-Screening Program for Cervical Carcinomas. Journal of Evolution
More informationAcceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index
DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila
More informationComparison between Siriraj Liquid-based and Conventional Cytology for Detection of Abnormal Cervicovaginal Smears: A Split-sample Study
Comparison between Liquid-based and Conventional Cytology in Thailand RESEARCH COMMUNICATION Comparison between Siriraj Liquid-based and Conventional Cytology for Detection of Abnormal Cervicovaginal Smears:
More informationInternational Journal of Biological & Medical Research
Int J Biol Med Res. ; 2(3): 757-761 Int J Biol Med Res www.biomedscidirect.com Volume 2, Issue 3, July BioMedSciDirect Publications Contents lists available at BioMedSciDirect Publications International
More informationComparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination
ORIGINAL ARTICLE Comparative Study of Pap Smear Quality by using Ayre s Spatula versus Ayre s Spatula and Cytobrush Combination Numi Anjum 1, B Sindhoora 2 1. Tutor, Department of Obstetrics and Gynecology
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationThe Bethesda System: Updates for th Cytopathology Congress Bursa, Turkey October 14, 2015
HARVARD MEDICAL SCHOOL The Bethesda System: Updates for 2015 6th Cytopathology Congress Bursa, Turkey October 14, 2015 David C. Wilbur, M.D. Dept. of Pathology Massachusetts General Hospital DISCLOSURES
More informationNegative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?
Anatomic Pathology / FALSE-NEGATIVE HISTOLOGIC FINDINGS Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?
More informationUtility of Pap Smear in Cervical Screening in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 319-323 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.039
More informationDepartment of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal
Kathmandu University Medical Journal (2007), Vol. 5, No. 4, Issue 20, 461-467 Original Article Correlation of PAP smear findings with clinical findings and cervical biopsy Pradhan B 1, Pradhan SB 2, Mital
More informationCan LBC Completely Replace Conventional Pap Smear in Developing Countries
The Journal of Obstetrics and Gynecology of India (January February 2019) 69(1):69 76 https://doi.org/10.1007/s13224-018-1-7 ORIGINAL ARTICLE Can LBC Completely Replace Conventional Pap Smear in Developing
More informationdifficult and may not be practical. Nevertheless, the performance characteristics of rapid screening have not been completely characterized.
Anatomic Pathology / PERFORMANCE CHARACTERISTICS OF RAPID PRESCREENING Performance Characteristics of Rapid (0-Second) Prescreening Implications for Calculating the False-Negative Rate and Comparison With
More informationCytology Report Format
Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College
More informationDepartment of Pathology, Hvidovre Hospital, Copenhagen University Hospital, Copenhagen, Denmark
Comparison of conventional Papanicolaou smear and SurePath Ò liquid-based cytology in the Copenhagen population screening programme for cervical cancer B. Kirschner, K. Simonsen and J. Junge Department
More informationComparative Study of Pap Smear and Cervical Biopsy Findings
Original paper Comparative Study of Pap Smear and Cervical Biopsy Findings ^* ^Department of pathology/ College of medicine/ Kerbala University/Kerbala/ Iraq. Abstract B ackground: Pap smear is the most
More informationchapter 4. The effect of oncogenic HPV on transformation zone epithelium
chapter 4. The effect of oncogenic HPV on transformation zone epithelium CHAPTER 1 All squamous cervical cancer (and probably all cervical adenocarcinoma) is associated with oncogenic HPV, and the absence
More informationSuthi Sangkarat, Somsak Laiwejpithaya, Manee Rattanachaiyanont, Pattama Chaopotong*, Mongkol Benjapibal, Weerasak Wongtiraporn, Sujera Laiwejpithaya
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.5.2051 RESEARCH ARTICLE Performance of Siriraj Liquid-Based Cytology: a Single Center Report Concerning over 100,000 Samples Suthi Sangkarat, Somsak Laiwejpithaya,
More informationAssociate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.
Assessment of Visual Inspection with Acetic Acid (VIA) as a Screening Test for Cervical Neoplasia in Comparison with Cytologic Screening in Imam Khomeini Hospital F. Ghaemmaghami, MD Associate Professor
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Cytodiagnostic Study of Cervical Lesions Using the Bethesda System with Histopathological Tahera
More informationBC Cancer Cervix Screening 2015 Program Results. February 2018
BC Cancer Cervix Screening 2015 Program Results BC Cancer Cervix Screening 2015 Program Results 2 Table of Contents BC Cancer Cervix Screening 2015 Program Results... 1 Table of Contents... 2 Program Overview...
More informationCan Human Papillomavirus DNA Testing Substitute for Cytology in the Detection of High-Grade Cervical Lesions?
Can Human Papillomavirus DNA Testing Substitute for Cytology in the Detection of High-Grade Cervical Lesions? Kyung-Ju Lee, MD; Jae-Kwan Lee, MD; Ho-Suk Saw, MD, PhD Context. High-risk human papillomaviruses
More informationComparative study of human papilloma virus DNA detection and results of histopathological examination of cervical colposcopic biopsy
Iranian Journal of Reproductive Medicine Vol.5. No.3. pp:121-126, Summer 2007 Comparative study of human papilloma virus DNA detection and results of histopathological examination of cervical colposcopic
More informationCervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationCervicovaginal Flora Comparison of Conventional Pap Smears and a Liquid-Based Thin-Layer Preparation
Anatomic Pathology / CERVICOVAGINAL FLORA Cervicovaginal Flora Comparison of Conventional Pap Smears and a Liquid-Based Thin-Layer Preparation Hidehiro Takei, MD, 1,2 Bernardo Ruiz, MD, PhD, 2 and John
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationInt J Clin Exp Pathol (2008) 1, Bhavini Carns 1, 2, 3 and Oluwole Fadare 1, 4. Introduction
www.ijcep.com/ijcep708013 Original Article Papanicolaou Test in the Detection of High-Grade Cervical Lesions: A Re-evaluation Based on Cytohistologic Non-correlation Rates in 356 Concurrently Obtained
More informationObjectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies
Cervical Cancer Screening Guidelines: Updates and Controversies I have no financial interests in any product I will discuss today. Jody Steinauer, MD, MAS University of California, San Francisco Objectives
More informationEvaluation of a Pap smear screening program for elderly women in Hong Kong
Blackwell Science, LtdOxford, UKAFMAsia Pacific Family Medicine1444-183 23 Blackwell Publishing Asia Pty LtdSeptember 2323117Original ArticlePap smear screening in the elderlyaoy Wong Asia Pacific Family
More informationCytohistologic Discrepancies A Means to Improve Pathology Practice and Patient Outcomes
Anatomic Pathology / CYTOHISTOLOGIC DISCREPANCIES Cytohistologic Discrepancies A Means to Improve Pathology Practice and Patient Outcomes Karen M. Clary, MD, Jan F. Silverman, MD, Yulin Liu, MD, PhD, Charles
More informationOriginal Policy Date
MP 2.04.03 Cervicography Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy Index Disclaimer
More informationPAP. Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) YEAR END SUMMARY REPORT. Anatomic Pathology Programs
2005 PAP Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) Surveys and Educational Anatomic Pathology Programs YEAR END SUMMARY REPORT 2005 College of American Pathologists. The
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,
More informationReporting Endometrial Cells in Women 40 Years and Older Assessing the Clinical Usefulness of Bethesda 2001
Anatomic Pathology / THE EFFECT OF BETHESDA 2001 ON REPORTING OF ENDOMETRIAL CELLS Reporting Endometrial Cells in Women 40 Years and Older Assessing the Clinical Usefulness of Bethesda 2001 Aylin Simsir,
More informationHuman papillomavirus typing in HIV-positive women
Infect Dis Obstet Gynecol ;9:89 93 Human papillomavirus typing in HIV-positive women Meera Hameed, Helen Fernandes, Joan Skurnick, Dorothy Moore, Patricia Kloser 3 and Debra Heller Department of Pathology
More informationOver-diagnoses in Cytopathology: Is histology the gold standard?
Over-diagnoses in Cytopathology: Is histology the gold standard? Teresa M. Darragh, MD UCSF Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences Faculty Disclosures: Teresa M. Darragh,
More informationAbnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing
280 Abnormal Cervicovaginal Cytology With Negative Human Papillomavirus Testing Giovanni Negri, MD Bettina Rigo, BS Fabio Vittadello, ScD Christine Mian, ScD Eduard Egarter-Vigl, MD Department of Pathology,
More informationAtypical squamous cells. The case for HPV testing
OBG MANAGEMENT FOCUS ON CERVICAL DISEASE BY J. THOMAS COX, MD ASC-US is most often due to transient changes or HPV. HPV-positive ASC-US is 12.5 to 23 times more likely to be associated with CIN 2,3 on
More informationChapter 10: Pap Test Results
Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the
More informationHigh-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics, and Clinical Meaning for Cervical Cancer
103 Ivyspring International Publisher Research Paper International Journal of Medical Sciences 2012; 9(1):103-107 High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics,
More informationCan HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation?
Anatomic Pathology / Monitoring HPV-16 Fractions in CIN Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Mary T. Galgano, MD, 1 Philip E. Castle, PhD, MPH, 2 Mark
More informationMaterials and Methods
Accuracy of Diagnosis of Atypical Glandular Cells Conventional and ThinPrep Reena Ramsaroop, M.B., Ch.B., F.F.Path., Ph.D.* and Ien Chu, N.Z.I.M.L.T., Q.T.A., Q.T.O. The incidence of glandular cervical
More informationBiomed Environ Sci, 2015; 28(1): 80-84
80 Biomed Environ Sci, 2015; 28(1): 80-84 Letter to the Editor Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study* YANG Yi1, LANG Jing He1, WANG You Fang1, CHENG
More informationStudy of Cervical Pap Smears in a Tertiary Hospital
250 Original Study Study of Cervical Pap Smears in a Tertiary Hospital Sunita A. Bamanikar, Professor, Department of Pathology, Dadaso S. Baravkar, Resident Pathologist, Department of Pathology, Shirish
More informationThe Bethesda System for Reporting Cervical Cytology: A Historical Perspective
Commentary Received: May 17, 2017 Accepted after revision: May 18, 2017 Published online: July 11, 2017 The Bethesda System for Reporting Cervical Cytology: A Historical Perspective Ritu Nayar a David
More informationMojgan Karimi-Zarchi, Fateme Peighmbari, Neda Karimi, Mitra Rohi, Zohre Chiti. Shahid Sadoughi University of Medical Science, Yazd, Iran
International journal of Biomedical science ORIGINAL ARTICLE A Comparison of 3 Ways of Conventional Pap Smear, Liquid- Based Cytology and Colposcopy vs Cervical Biopsy for Early Diagnosis of Premalignant
More informationCervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationHPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in China
2436 Ivyspring International Publisher Research Paper Journal of Cancer 2017; 8(13): 2436-2441. doi: 10.7150/jca.19421 HPV test results and histological follow-up results of patients with LSIL Cervical
More informationWelcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013
THE ROLE OF oncofish cervical IN THE ASSESSMENT OF CERVICAL DYSPLASIA The phone lines will open, 15 minutes prior to the start of the webinar. Toll Free: 1-800-867-0864. Entry Code: 83956484. You may download
More informationEU guidelines for reporting gynaecological cytology
EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationEffectiveness of the ThinPrep Imaging System:
Effectiveness of the ThinPrep Imaging System: Clinical Experience in a Low Risk Screening Population Jacalyn L. Papillo, B.S., C.T., A.S.C.P., 1 * Timothy L. St. John, B.S., C.T., A.S.C.P., 1 and Gladwyn
More informationWhat is a Pap smear?
Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years
More informationThyroid Cytopathology: Weighing In The Bethesda System
Thyroid Cytopathology: Weighing In The Bethesda System V8 Conflicts No financial consideration Bias Work in the Canadian environment where litigation is less Thyroid cytology is often referred in by small
More informationUnderstanding Your Pap Test Results
Understanding Your Pap Test Results Most laboratories in the United States use a standard set of terms called the Bethesda System to report pap test results. Normal: Pap samples that have no cell abnormalities
More informationInstructions For Use
MAN-02624-001 Rev. 004 page 1 of 15 Instructions For Use INTENDED USE The ThinPrep 2000 System is intended as a replacement for the conventional method of Pap smear preparation for use in screening for
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Screening Update and Implications for Annual Exams George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics
More informationAssisted Primary Screening Using the Automated ThinPrep Imaging System
Anatomic Pathology / THINPREP AUTOMATED CERVICAL SCREENING Assisted Primary Screening Using the Automated ThinPrep Imaging System Charles V. Biscotti, MD, 1 Andrea E. Dawson, MD, 1 Bruce Dziura, MD, 2
More informationImproved Detection of Cervical Cancer and High Grade Neoplastic Lesions by a Combination of Conventional Cytology and DNA Automated Image Cytometer
Journal of Cancer Therapy, 2010, 1, 47-51 doi:10.4236/jct.2010.12008 Published Online June 2010 (http://www.scirp.org/journal/jct) 47 Improved Detection of Cervical Cancer and High Grade Neoplastic Lesions
More informationAnatomic Pathology / CONVENTIONAL VS AUTOMATED PAPANICOLAOU SMEAR SCREENING
Anatomic Pathology / CONVENTIONAL VS AUTOMATED PAPANICOLAOU SMEAR SCREENING Can Technology Expedite the Cervical Cancer Screening Process? A Hong Kong Experience Using the AutoPap Primary Screening System
More informationClinical utility of Liqui-PREP cytology system for primary cervical cancer screening in a large urban hospital setting in China
Original Article Clinical utility of Liqui-PREP cytology system for primary cervical cancer screening in a large urban hospital setting in China ABSTRACT Background: Liquid based cytology (LBC) has been
More informationColposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
More informationCervical Cancer : Pap smear
Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective
More informationHKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists
HKCOG Guidelines Guidelines on the Management of An Abnormal Cervical Smear Number 3 revised November 2002 published by The Hong Kong College of Obstetricians and Gynaecologists A Foundation College of
More informationInt. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)
Int. J. Life. Sci. Scienti. Res., 2(3): -279-284 (ISSN: 2455-1716) Impact Factor 2.4 MAY-2016 Research Article (Open access) Detection of Abnormal Cervical Cytology by Papanicolaou Stained (PAP) Smears
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationAtypical And Suspicious Categories In Fine Needle Aspiration Cytology Of The Breast
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-853, p-issn: 2279-861.Volume 15, Issue 1 Ver. III (October. 216), PP 57-61 www.iosrjournals.org Atypical And Suspicious Categories in
More informationCytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.
Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med
More informationLesions of uterine cervix by cytology and histopathology- A prospective study for a period of two years
Original Research Article DOI: 10.18231/2394-6792.2017.0040 Lesions of uterine cervix by cytology and histopathology- A prospective study for a period of two years Deepthi KN 1,*, Aravinda Macharla 2 1,2
More informationSQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)
SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H) ASC refers to cytologic changes suggestive of SIL, which are qualitativley or quantitatively
More informationCourse Title: Thin Prep PAP Smears. Number of Clock Hours: 3 Course Title #
Course Title: Thin Prep PAP Smears Number of Clock Hours: 3 Course Title #5240303 Course Introduction There is a new laboratory test that is gaining popularity as a cancer screening tool for cervical cancer.
More informationNILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA
NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA Focused Rescreening Prior to Report Issuance, An Enhanced Quality Control Measure Karen Cormier, CT(ASCP), 1 Michael
More informationCervical Cancer Screening Update. Melissa Hartman, DO Women s Health
Cervical Cancer Screening Update Melissa Hartman, DO Women s Health Previous Cervical Cancer Screening Organization Recommendation ACS (2011) ACP (2008) NCI (2003) Age 21 or 3 years after first intercourse
More informationSydney Gynaecology Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
bs_bs_banner doi:10.1111/jog.12545 J. Obstet. Gynaecol. Res. Vol. 41, No. 3: 440 444, March 2015 Abnormal cervicovaginal cytology, unsatisfactory colposcopy and the use of vaginal estrogen cream: An observational
More information